Slow release lanreotide in combination with Interferon-a2b in the treatment of symptomatic advanced medullary thyroid carcinoma. - Vitale,G.; Tagliaferri,P.; Caraglia,M.; Rampone,E.; Ciccarelli,A.; Bianco,A.R.; Abbruzzese,A.; Lupoli,G. (J Clin Endocrinol Metab, 2000)